Massive registry launches to see how brain aneurysm devices perform in real life
NCT ID NCT07474935
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This registry is following 5,000 people who receive WallabyPhenox flow diverters or other devices to treat brain aneurysms, dissections, or perforations. Researchers are tracking safety, performance, and patient outcomes over time in routine hospital practice. The goal is to gather real-world evidence on how well these devices work outside of controlled clinical trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Neurovascular flow diverter devices (p64, p48, and HPC variants)
What this could lead to
If successful, this registry will provide real-world data on how safe and effective these devices are for treating brain aneurysms and related conditions.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by differences in patient care across hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSEUDOANEURYSM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ASST Grande Ospedale Metropolitano Niguarda, Milano
NOT_YET_RECRUITINGMilan, 20162, Italy
Contact Email: •••••@•••••
-
Antonio Cardarelli Hospital- Naples
NOT_YET_RECRUITINGNaples, 80131, Italy
Contact
Contact
-
CHU Brest - Hôpital de La Cavale Blanche
RECRUITINGBrest, 29200, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Cannizzaro Hospital in Catania
NOT_YET_RECRUITINGCatania, 95126, Italy
Contact
Contact Email: •••••@•••••
-
Helios Klinikum Erfurt
NOT_YET_RECRUITINGErfurt, 99089, Germany
Contact Email: •••••@•••••
-
Kantonsspital St.Gallen
NOT_YET_RECRUITINGSankt Gallen, 9007, Switzerland
Contact Email: •••••@•••••
-
Klinikum Nürnberg
NOT_YET_RECRUITINGNuremberg, 90471, Germany
Contact Email: •••••@•••••
-
LMU Klinikum
NOT_YET_RECRUITINGMünchen, 81377, Germany
Contact Email: •••••@•••••
-
Pitié Salpêtrière Hospital
NOT_YET_RECRUITINGParis, 75013, France
Contact Email: •••••@•••••
-
University Hospital Heidelberg
NOT_YET_RECRUITINGHeidelberg, 69120, Germany
Contact Email: •••••@•••••
-
Universitätsklinikum Hamburg-Eppendorf
NOT_YET_RECRUITINGHamburg, 20246, Germany
Contact Email: •••••@•••••
-
Universitätsspital Basel
NOT_YET_RECRUITINGBasel, 4031, Switzerland
Contact Email: •••••@•••••
-
Univerzitná nemocnica L. Pasteura Košice
RECRUITINGKošice, 040 11, Slovakia
Contact Phone: •••-•••-•••• Email: •••••@•••••